Dupilumab demonstrated superiority over Omalizumab in Chronic Rhinosinusitis with Nasal Polyps
Regeneron Pharmaceuticals, Inc. and Sanofi presented positive results from the EVEREST Phase 4 trial in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In the trial, Dupixent.












